Ontology highlight
ABSTRACT: NCIC CTG MA.22 phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer on 2-weekly or 3-weekly schedules
PROVIDER: PRJNA278663 | ENA |
REPOSITORIES: ENA
ACCESS DATA